Resistance In Gram +ve Flashcards

1
Q

High priority pathogens (WHO list)

A

•enterococcus faecium
•staphylococcus aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Medium priority pathogens (WHO)

A

•streptococcus pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Staphylococcus aureus resistance mechanism

A

•produce beta lactamase
•destroys penicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Enterococci resistance

A

•inherent resistance/tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Streptococcus Pneumoniae resistance mechanism

A

•alter Penicillin binding proteins (PBP)
•reduced affinity for beta lactams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the functions of PBPs (penicillin binding proteins)

A

•provides cross linking between NAG and NAM in peptidoglycan cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do beta lactam antibiotics affect cell wall

A

•PBPs recognise D-ala-D-ala
•beta lactams mimic this
•PBPs bind beta lactams instead
•cross linking disrupts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do beta lactamases do

A

•hydrolyse beta lactam ring between N and O
•creates penicillioc acid instead
•ineffective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the effective part of penicillins

A

•the beta lactam ring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is flucloxacillin used for

A

•beta lactamase producing staphylococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does flucloxacillin work for staphylococcus but penicillin does not

A

•became resistant to penicillin
•bulky side chains added to make flucloxacillin prevent beta lactamase from working

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the spectrum of flucloxacillin

A

•very narrow
•developed for beta lactamase producing staphylococcus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is MRSA

A

Methicillin resistant staphylococcus aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How did MRSA begin

A

•methicillin introduced after penicillin resistance
•s aureus became resistant to methicillin and MRSA spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanism of MRSA resistance

A

•expression of PBP2a - resists methicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What encodes for PBP2a

A

•mecA on staphylococcal chromosomal cassette (SSCmec)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the target for methicillin resistance tests

A

•mecA gene on staphylococcal chromosomal cassette

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What caused the MRSA epidemic

A

•clonal spread of S. Aureus strains containing SCCmec
•not individual mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is SCCmec

A

•operon in MRSA
•encoding for mecA (PBP2a)

20
Q

How did they reduce MRSA rates

A

•reporting and surveillance of bacteraemia
•infection control
•bacteraemia targets

21
Q

Bacteraemia meaning

A

Presence of bacteria in the bloodstream

22
Q

What can enterococci cause

A

•UTI
•bowel sepsis

23
Q

What enterococci make up >90% of human isolates of enterococcus

A

•E. Faecalis
•E. Faecium

24
Q

How are enterococci tolerant

A

•contain PBPs with low affinity for beta lactams and glycopeptides
•inhibited by clinical concentrations
•only killed if excess of MIC

25
Q

Synergy meaning

A

Cooperation of >1 substances to produce combined effect better than if individual

26
Q

How can enterococci tolerance be overcome

A

•synergy
•combine cell walls active agent with aminoglycoside

27
Q

Antibiotic combination to treat enterococci

A

•gentamicin + penicillin or vancomycin

28
Q

What is E. Faecium resistant to

A

Vancomycin

29
Q

What are the 6 phenotypes for vancomycin resistance

30
Q

Clinically significant vancomycin resistant phenotypes

A

VanA and VanB

31
Q

Most common vancomycin resistant phenotype

32
Q

How many genes does the VanA/B phenotype contains

A

•7 genes in 2 clusters (VANA +VANB)

33
Q

Describe VanA resistance

A

•high resistant to vancomycin and teicoplanin
•alter PBP - D-ala-D-ala becomes D-ala-D-lac

34
Q

Describe VanB resistance

A

•variable resistance to vancomycin
•susceptible to teicoplanin

35
Q

What is VRE

A

Vancomycin resistant enterococci

36
Q

How does/did VRE evolve

A

High risk patients who have been treated with glycopeptides
*incorrect antibiotic use rather than infection control like MRSA

37
Q

How to mediate VRE

A

Antibiotic stewardship

38
Q

Main places/treatments where VRE evolves

A

•Haemodialysis
•Haematology
•Critical Care

39
Q

Treatments for VRE

A

•quinupristin-dalfopristin
•linezolid
•daptomycin
•tigecycline

40
Q

What is VRSA

A

•S. Aureus aquired VanA gene found in enterococci

41
Q

How do pneumococcals become resistant to beta-lactams

A

•alter PBPs
•alters to PBP types - 2x, 2b, 1a

42
Q

Six PBPs S. Pneumonia contains

A

•1a, 1b, 2a, 2b, 2x, 3

43
Q

What is standard treatment for meningitis

A

•cephalosporin (ceftriaxone)

44
Q

How are pneumococci resistant to cephalosporin

A

•alterations of PBP - 1a, 2x

45
Q

Treatments for childhood meningitis - with previous antibiotic use or travel out of the UK in past 3 months

A

Vancomycin